Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/185521
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPeremiquel Trillas, Paula-
dc.contributor.authorSaura Lázaro, Anna-
dc.contributor.authorBenavente Moreno, Yolanda-
dc.contributor.authorCasabonne, Delphine-
dc.contributor.authorLoureiro, Eva-
dc.contributor.authorCabrera Jaime, Sandra-
dc.contributor.authorDuran, Angela-
dc.contributor.authorGarrote, Lidia-
dc.contributor.authorBrao, Immaculada-
dc.contributor.authorTrelis, Jordi-
dc.contributor.authorGalán, Maica-
dc.contributor.authorSoler, Francesc-
dc.contributor.authorJulià, Joaquim-
dc.contributor.authorCortasa, Dolça-
dc.contributor.authorDomínguez Luzón, Ma. Ángeles (María Ángeles)-
dc.contributor.authorAlbasanz Puig, Adaia-
dc.contributor.authorGudiol, Carlota-
dc.contributor.authorRamírez Tarruella, Dolors-
dc.contributor.authorMuniesa, Joan-
dc.contributor.authorRivas, Juan Pedro-
dc.contributor.authorMuñoz Montplet, Carles-
dc.contributor.authorSedano, Ana-
dc.contributor.authorPlans, Àngel-
dc.contributor.authorCalvo Cerrada, Beatriz-
dc.contributor.authorCalle, Candela-
dc.contributor.authorClopés Estela, Ana-
dc.contributor.authorCarnicer Pont, Dolors-
dc.contributor.authorAlemany, Laia-
dc.contributor.authorFernández Muñoz, Esteve-
dc.date.accessioned2022-05-13T08:03:41Z-
dc.date.available2022-05-13T08:03:41Z-
dc.date.issued2022-04-01-
dc.identifier.urihttp://hdl.handle.net/2445/185521-
dc.description.abstractObjectives Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. Design Cross-sectional study (21 May 2020-26 June 2020). Setting A comprehensive cancer centre (Institut Catala d'Oncologia) in Catalonia, Spain. Participants All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. Primary outcome measure Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. Results A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25-p75: 34.8-51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). Conclusions At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Catala d'Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBMJ-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1136/bmjopen-2021-056637-
dc.relation.ispartofBMJ Open, 2022, vol. 12, num. 4, p. e056637-
dc.relation.urihttps://doi.org/10.1136/bmjopen-2021-056637-
dc.rightscc by (c) Peremiquel Trillas, Paula et al., 2022-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationPandèmia de COVID-19, 2020--
dc.subject.classificationSARS-CoV-2-
dc.subject.classificationHospitals-
dc.subject.otherCOVID-19 Pandemic, 2020--
dc.subject.otherSARS-CoV-2-
dc.subject.otherHospitals-
dc.titleCOVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec730475-
dc.date.updated2022-05-12T10:10:11Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid35450905-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
e056637.full.pdf754.69 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons